DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02179 RECBIO-B

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Taizhou Yuangong Technology Partnership (Limited Partnership) (17.16%)
Legend Capital Co., Ltd (9.89%)
Shenzhen Oriental Fortune Capital Investment Co., Ltd. (6.86%)
Shanghai Chaorui Medical Technology Partnership (Limited Partnership) (6.19%)
Beijing Juncheng Hezhong Investment Management Partnership (Limited Partnership) (5.87%)
Shenzhen Fer-Capital Investment Co., Ltd. (5.63%)		 Sector Health Care & Biotechnology
Web Site http://www.recbio.cn Tel (86 523) 8681-8860
Email ir@recbio.cn Fax N/A
Related Equities N/A
Principal Activities Principally engaged in the research and development of vaccines in Mainland China.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top